Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses
Valeria Napolitano(Helmholtz Zentrum München), Krzysztof Pyrć(Jagiellonian University)
Cited by 61
Related Papers
APOBEC3-mediated restriction of RNA virus replication
|Scientific Reports|2018|129
Zika virus: mapping and reprogramming the entry
|Cell Communication and Signaling|2019|35
Novel inhibitors of HSV-1 protease effective in vitro and in vivo
|Antiviral Research|2023|11
Development of an intestinal mucosa <i>ex vivo</i> co-culture model to study viral infections
|Journal of Virology|2024|4